GLOBAL CANCER TARGETED THERAPY MARKET 2019 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Jun 2019 135

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Scope of the Report:
The global Cancer Targeted Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Targeted Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cancer Targeted Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Targeted Therapy market by product type and applications/end industries.

Market Segment by Companies, this report covers
- Advaxis
- Bind Therapeutics
- Boehringer Ingelheim
- Bristol Mayer Squibb
- Celldex Therapeutics
- Dendreon Corporation
- Eli Lily
- GalaxoSmithKline
- Galena Biopharma
- Genetech
- ImmunoCellular Therapeutics
- ImmunoGen
- Inovio Pharmaceuticals
- Johnson & Johnson
- NeoStem Oncology
- NewLink Genetics
- Northwest Biotherapeutics
- Merck
- Novartis
- Peregrine Pharmaceuticals
- Pfizer
- Roche
- Sanofi
- Seattle Genetics
- Teva

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Tumor Antigens As Targets of Antibodies
- Development of Antibodies for Clinical Purposes
- Complement Dependent Cytotoxicity (CDC)
- Signal Transduction Changes

Market Segment by Applications, can be divided into
- Hospital
- Clinic
- Other

Table of Contents

Related reports :

(Jun 19)

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemo...

(Jun 19)

Scope of the Report: The global Cancer Immunotherapy Drug Discovery Outsourcing market is valued at xx million USD in 2018 and is exp...

(Jun 19)

Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism...

(Jun 19)

Neuro Emotional Technique (NET) is a psycho-emotional therapy based on the physiological foundations of stress-related responses. As discove...

(Jun 19)

Scope of the Report: The worldwide market for Cervical Cancer Treatment is expected to grow at a CAGR of roughly xx% over the next fi...

(Jun 19)

Scope of the Report: The worldwide market for Nasal Drug Delivery Technology is expected to grow at a CAGR of roughly xx% over the ne...

GLOBAL CANCER TARGETED THERAPY MARKET 2019 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use JUNE15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy